Merck reported a mixed third quarter update on Thursday, cutting guidance even as earnings topped market expectations.The readout didn’t seem to be enough to change the narrative around the stock, ...

As the 11th Merck Foundation Africa Asia Luminary opens in Tanzania, stakeholders have emphasised the crucial role of healthcare in driving economic and social progress. They spoke at the opening ...

Having an official Hyundai service manual on hand is a bit like having a trusty sage in the garage—it’s a wise decision for any DIY enthusiast. These manuals are a gold mine of information, ...

Merck will face an important patent cliff by the end of the decade. The company has a plan to move beyond it. Competition from a new therapy shouldn't derail Merck's prospects. Even when we zoom ...

Oct. 23, 2024 (GLOBE NEWSWIRE) -- Modifi Biosciences, Inc. (“Modifi Biosciences”), a leader in the development of direct DNA modification enabled cancer therapeutics, today announced that the company ...

In a 14-1 vote, the panel moved to expand its usage recommendation for both Pfizer’s Prevnar 20 and Merck’s Capvaxive to include all adults aged 50 and older as well as adults between 19 and ...

Merck & Co. is putting down $30 million upfront to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset designed to take on the tough-to-treat brain cancer glioblastoma (GBM).

Merck’s MRK stock has declined 14.4% in the past six months against an increase of 9.7% for the Large Cap Pharmaceuticals industry. The stock has also underperformed the sector and the S&P 500 ...

In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against the other US stocks. Despite previous recession predictions, the market has shown resilience and ...

Belen Garijo took charge of German drug-to-semiconductor group Merck KGaA with the tailwind of the Covid pandemic, propelling the stock to an all-time high in 2021. Since then, the shares have ...